Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Organon & Co.
Bear Case (25th pct.)
-13.6% vs price
Base Case (Median)
6.0% vs price
Bull Case (75th pct.)
27.6% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| PE Comparable | $17.51 | 27.7% | Medium (25%) |
| Graham Number | $7.09 | -48.3% | Medium (40%) |
| EV/EBITDA | $17.51 | 27.6% | Medium (20%) |
| EV/FCF | $11.86 | -13.6% | Medium (20%) |
| Earnings Power Value | $14.54 | 6.0% | Medium (50%) |
Based on 5 out of 7 methods, OGN appears fairly valued at the current price of $13.72. The base case fair value of $14.54 implies 6.0% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.